Skip to main content
Top
Literature
2.
go back to reference Aggarwal SP, Priyadarshi S, Tomar V, Yadav SS, Gangkak G, Vyas N et al (2015) A randomized controlled trial to compare the safety and efficacy of tadalafil and tamsulosin in relieving Double J stent related symptoms. Adv Urol 2015:592175CrossRef Aggarwal SP, Priyadarshi S, Tomar V, Yadav SS, Gangkak G, Vyas N et al (2015) A randomized controlled trial to compare the safety and efficacy of tadalafil and tamsulosin in relieving Double J stent related symptoms. Adv Urol 2015:592175CrossRef
3.
go back to reference Bhattar R, Tomar V, Yadav SS, Dhakad DS (2018) Comparison of safety and efficacy of silodosin, solifenacin, tadalafil and their combinations in the treatment of double-J stent-related lower urinary system symptoms: a prospective randomized trial. Turk J Urol 44(3):228–238CrossRef Bhattar R, Tomar V, Yadav SS, Dhakad DS (2018) Comparison of safety and efficacy of silodosin, solifenacin, tadalafil and their combinations in the treatment of double-J stent-related lower urinary system symptoms: a prospective randomized trial. Turk J Urol 44(3):228–238CrossRef
4.
go back to reference Tharwat M, Elsaadany MM, Lashin AM, El-Nahas AR (2018) A randomized controlled trial evaluating sildenafil citrate in relieving ureteral stent-related symptoms. World J Urol 36(11):1877–1881CrossRef Tharwat M, Elsaadany MM, Lashin AM, El-Nahas AR (2018) A randomized controlled trial evaluating sildenafil citrate in relieving ureteral stent-related symptoms. World J Urol 36(11):1877–1881CrossRef
5.
go back to reference Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. version 5.3.0 [Internet]. The Cochrane Collaboration. Available from: www.cochrane-handbook.org. Accessed 18 July 2019 Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. version 5.3.0 [Internet]. The Cochrane Collaboration. Available from: www.​cochrane-handbook.​org. Accessed 18 July 2019
6.
go back to reference Berkman ND, Lohr KN, Ansari M, McDonagh M, Balk E, Whitlock E et al Grading the strength of a body of evidence when assessing health care interventions for the effective health care program of the Agency for Healthcare Research and Quality: an update. AHRQ Publication No. 13(14)-EHC130-EF. Agency for Healthcare Research and Quality, Rockville. www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed July 2019 Berkman ND, Lohr KN, Ansari M, McDonagh M, Balk E, Whitlock E et al Grading the strength of a body of evidence when assessing health care interventions for the effective health care program of the Agency for Healthcare Research and Quality: an update. AHRQ Publication No. 13(14)-EHC130-EF. Agency for Healthcare Research and Quality, Rockville. www.​effectivehealthc​are.​ahrq.​gov/​reports/​final.​cfm. Accessed July 2019
Metadata
Title
Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis
Authors
Zhongbao Zhou
Zhenli Gao
Jitao Wu
Yuanshan Cui
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 8/2020
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02893-6

Other articles of this Issue 8/2020

World Journal of Urology 8/2020 Go to the issue